Bayer Yakuhin, Ltd. and Alinamin Pharmaceutical Co., Ltd. have begun over-the-counter sales of Elevit, a multivitamin supplement for women trying to conceive and during pregnancy, at drugstores and pharmacies nationwide. Alinamin Pharmaceutical will begin sales in original packaging on 9 September.
Bayer Yakuhin, Ltd. and Alinamin Pharmaceutical Co., Ltd. have entered into a business partnership agreement aimed at expanding awareness and enhancing the brand value of Elevit, the world’s No. 1 multivitamin supplement for women trying to conceive and during pregnancy, in Japan, and will begin selling the product in original packaging at drugstores and pharmacies nationwide from 9 September.
Elevit is designed to provide 18 nutrients, including 800 μg of folic acid and vitamin D, in 3 tablets per day, and to provide a balanced supplement of nutrients considered necessary for women trying to conceive and during pregnancy. The article also discusses clinical trial results in Japan, quality standards and the manufacturing system.
As background to the partnership, Bayer Yakuhin highlights the brand strength derived from its research track record and expertise in maternal and child nutrition, while Alinamin Pharmaceutical emphasizes its evidence base and sales platform in the self-medication field. The companies plan to jointly promote the provision of nutritional information and expansion of brand awareness from the period of preparing to conceive through pregnancy. The article also includes information on Elevit’s proprietary Stork Formula and its new formulation, which increased vitamin D by approximately 3 times in March 2026.